Development of patient-derived tumor organoids and a drug testing model for renal cell carcinoma

The selection of effective therapeutic agents is critical for improving the survival of patients with renal cell carcinoma (RCC). The aim of the present study was to develop an ex vivo drug testing assay using patient-derived tumor organoid (TO) cultures. For this purpose, surgical tumor specimens w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazama, Akira, Anraku, Tsutomu, Kuroki, Hiroo, Shirono, Yuko, Murata, Masaki, Bilim, Vladimir, Ugolkov, Andrey, Saito, Kazuhide, Tomita, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424486/
https://www.ncbi.nlm.nih.gov/pubmed/34468011
http://dx.doi.org/10.3892/or.2021.8177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424486/
https://www.ncbi.nlm.nih.gov/pubmed/34468011
http://dx.doi.org/10.3892/or.2021.8177

Ejemplares similares